The Associate Ophthalmologist Part 2: Physician Partnership Opportunities Under The PE Model
As mentioned in our previous post, there are many questions swirling around private equity investments in ophthalmology practices. Some particularly important ones relate to how a transaction will alter the career trajectory of associate ophthalmologists – particularly those with an interest in partnership. Is there upside for physicians who did not participate in the initial equity transaction? Will they ever have an opportunity to gain an equity position in the practice? The answer is yes, and here’s why.
Private equity investors are heavily focused on aligned incentivizes for all physicians as they consider medical practice investments. To successfully grow a practice, they depend on associate physicians’ continued involvement and ultimately, leadership. Private investors will not be successful unless young ophthalmologists thrive within the new partnership structure. After all, associate physicians will be the leaders that perpetuate practices for decades to come. Thus, investors are creating unique equity structures and partnership buy-in opportunities that align incentives for both individual practices and their global ophthalmology companies. Oftentimes, these new systems provide additional upside with lower personal risk – a highly attractive profile for younger physicians.
PLATFORM EQUITY BUY-IN
Private equity-backed ophthalmology platforms are utilizing platform equity positions – usually some form of stock in the larger ophthalmology company – as an incentive for associate ophthalmologists. Many firms have developed partnership programs with defined performance targets where associates are offered a structured opportunity to buy-in. Both the private equity investors and physician partners hope and expect this equity to yield high returns during future recapitalizations of the ophthalmology platform.
NEW INCENTIVE ALTERNATIVES EMERGING
Each investor is unique, and so are the partnership opportunities available across this ecosystem. New incentivization programs are being developed that mimic stock option agreements and other structures that have been successful throughout the business world. As private investment in ophthalmology continues to mature, we can expect these programs to evolve to meet the desires of young ophthalmologists seeking a good career fit with stability and upside.
For more information on selling your ophthalmology practice and Physicians First's investment banking solution, download our current report here.
This post is for informational purposes only and does not constitute an offer, invitation, solicitation, or recommendation to buy, sell, subscribe for, or issue any securities. While the information provided herein is believed to be accurate and reliable, 127 Capital, LLC (“Physicians First”) and Ashland Securities, LLC make no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person. Certain Principals of Physicians First are registered representatives of Ashland Securities, LLC Member FINRA, SIPC. Physicians First and Ashland Securities, LLC are separate and unaffiliated entities. Securities and Investment Banking Services are offered through Ashland Securities, LLC.